These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26239109)

  • 1. In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.
    Stellari F; Bergamini G; Sandri A; Donofrio G; Sorio C; Ruscitti F; Villetti G; Assael BM; Melotti P; Lleo MM
    J Transl Med; 2015 Aug; 13():251. PubMed ID: 26239109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
    Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
    Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
    Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo monitoring of lung inflammation in CFTR-deficient mice.
    Stellari F; Bergamini G; Ruscitti F; Sandri A; Ravanetti F; Donofrio G; Boschi F; Villetti G; Sorio C; Assael BM; Melotti P; Lleo MM
    J Transl Med; 2016 Jul; 14(1):226. PubMed ID: 27468800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.
    Bergamini G; Stellari F; Sandri A; M Lleo M; Donofrio G; Ruscitti F; Boschi F; Sbarbati A; Villetti G; Melotti P; Sorio C
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28715404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa.
    Kimura S; Mori N; Kai T; Ishii Y; Yamaguchi K; Tateda K
    J Infect Chemother; 2017 Aug; 23(8):550-555. PubMed ID: 28579350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
    Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
    Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin regulates bacterial virulence and immune response in a murine model of ceftazidime-treated Pseudomonas aeruginosa acute pneumonia.
    Leroy AG; Caillon J; Broquet A; Lemabecque V; Delanou S; Caroff N; Asehnoune K; Roquilly A; Crémet L
    Microbiol Immunol; 2024 Feb; 68(2):27-35. PubMed ID: 38073281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.
    Kikuchi Y; Tateda K; Fuse ET; Matsumoto T; Gotoh N; Fukushima J; Takizawa H; Nagase T; Standiford TJ; Yamaguchi K
    Pulm Pharmacol Ther; 2009 Aug; 22(4):333-9. PubMed ID: 19162211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PA5470 Counteracts Antimicrobial Effect of Azithromycin by Releasing Stalled Ribosome in Pseudomonas aeruginosa.
    Shi J; Liu Y; Zhang Y; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203495
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
    Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
    Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection.
    Halldorsson S; Gudjonsson T; Gottfredsson M; Singh PK; Gudmundsson GH; Baldursson O
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):62-8. PubMed ID: 19372247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
    Saini H; Vadekeetil A; Chhibber S; Harjai K
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
    [No Abstract]   [Full Text] [Related]  

  • 19. Baicalein attenuates the quorum sensing-controlled virulence factors of Pseudomonas aeruginosa and relieves the inflammatory response in P. aeruginosa-infected macrophages by downregulating the MAPK and NFκB signal-transduction pathways.
    Luo J; Kong JL; Dong BY; Huang H; Wang K; Wu LH; Hou CC; Liang Y; Li B; Chen YQ
    Drug Des Devel Ther; 2016; 10():183-203. PubMed ID: 26792984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
    Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
    Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.